Aura Biosciences Inc
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the … Read more
Market Cap & Net Worth: Aura Biosciences Inc (AURA)
Aura Biosciences Inc (NASDAQ:AURA) has a market capitalization of $432.46 Million ($432.46 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #13842 globally and #5669 in its home market, demonstrating a 20.11% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Aura Biosciences Inc's stock price $6.81 by its total outstanding shares 63503269 (63.50 Million).
Aura Biosciences Inc Market Cap History: 2021 to 2026
Aura Biosciences Inc's market capitalization history from 2021 to 2026. Data shows change from $1.08 Billion to $432.46 Million (-16.23% CAGR).
Index Memberships
Aura Biosciences Inc is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.01% | #374 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #1332 of 3165 |
|
NASDAQ Biotechnology
NBI
|
$1.54 Trillion | 0.02% | #202 of 263 |
Weight: Aura Biosciences Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Aura Biosciences Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Aura Biosciences Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of AURA by Market Capitalization
Companies near Aura Biosciences Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Aura Biosciences Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Aura Biosciences Inc Historical Marketcap From 2021 to 2026
Between 2021 and today, Aura Biosciences Inc's market cap moved from $1.08 Billion to $ 432.46 Million, with a yearly change of -16.23%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $432.46 Million | +24.95% |
| 2025 | $346.09 Million | -33.70% |
| 2024 | $522.00 Million | -7.22% |
| 2023 | $562.64 Million | -15.62% |
| 2022 | $666.78 Million | -38.16% |
| 2021 | $1.08 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Aura Biosciences Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $432.46 Million USD |
| MoneyControl | $432.46 Million USD |
| MarketWatch | $432.46 Million USD |
| marketcap.company | $432.46 Million USD |
| Reuters | $432.46 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.